Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Impact of Obstructive Sleep Apnea on Neurocognitive Function and Impact of Continuous Positive Air Pressure.

Davies CR, Harrington JJ.

Sleep Med Clin. 2016 Sep;11(3):287-98. doi: 10.1016/j.jsmc.2016.04.006. Epub 2016 Jun 28. Review.

PMID:
27542875
2.

Design and feasibility of a memory intervention with focus on self-management for cognitive impairment in epilepsy.

Caller TA, Secore KL, Ferguson RJ, Roth RM, Alexandre FP, Henegan PL, Harrington JJ, Jobst BC.

Epilepsy Behav. 2015 Mar;44:192-4. doi: 10.1016/j.yebeh.2014.12.036. Epub 2015 Feb 27.

PMID:
25731132
3.

Predictors for readmissions after video-EEG monitoring.

Caller TA, Chen JJ, Harrington JJ, Bujarski KA, Jobst BC.

Neurology. 2014 Jul 29;83(5):450-5. doi: 10.1212/WNL.0000000000000647. Epub 2014 Jun 20.

4.

A mathematical framework for modelling cambial surface evolution using a level set method.

Sellier D, Plank MJ, Harrington JJ.

Ann Bot. 2011 Oct;108(6):1001-11. doi: 10.1093/aob/mcr067. Epub 2011 Apr 5.

5.

Investigation of 4-piperidinols as novel H3 antagonists.

Anderson JT, Campbell M, Wang J, Brunden KR, Harrington JJ, Stricker-Krongrad A, Song J, Doucette C, Murphy S, Bennani YL.

Bioorg Med Chem Lett. 2010 Nov 1;20(21):6246-9. doi: 10.1016/j.bmcl.2010.08.099. Epub 2010 Aug 24.

PMID:
20833043
6.

3-Indolyl sultams as selective CRTh2 antagonists.

Tumey LN, Robarge MJ, Gleason E, Song J, Murphy SM, Ekema G, Doucette C, Hanniford D, Palmer M, Pawlowski G, Danzig J, Loftus M, Hunady K, Sherf B, Mays RW, Stricker-Krongrad A, Brunden KR, Bennani YL, Harrington JJ.

Bioorg Med Chem Lett. 2010 Jun 1;20(11):3287-90. doi: 10.1016/j.bmcl.2010.04.046. Epub 2010 Apr 14.

PMID:
20457519
7.

GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome.

Pi M, Chen L, Huang MZ, Zhu W, Ringhofer B, Luo J, Christenson L, Li B, Zhang J, Jackson PD, Faber P, Brunden KR, Harrington JJ, Quarles LD.

PLoS One. 2008;3(12):e3858. doi: 10.1371/journal.pone.0003858. Epub 2008 Dec 3.

8.

High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay.

Zou H, Taylor WR, Harrington JJ, Hussain FT, Cao X, Loprinzi CL, Levine TR, Rex DK, Ahnen D, Knigge KL, Lance P, Jiang X, Smith DI, Ahlquist DA.

Gastroenterology. 2009 Feb;136(2):459-70. doi: 10.1053/j.gastro.2008.10.023. Epub 2008 Oct 15.

PMID:
19026650
9.

Stool DNA and occult blood testing for screen detection of colorectal neoplasia.

Ahlquist DA, Sargent DJ, Loprinzi CL, Levin TR, Rex DK, Ahnen DJ, Knigge K, Lance MP, Burgart LJ, Hamilton SR, Allison JE, Lawson MJ, Devens ME, Harrington JJ, Hillman SL.

Ann Intern Med. 2008 Oct 7;149(7):441-50, W81.

10.

Altered DNA mismatch repair expression in synchronous and metachronous colorectal cancers.

Aslanian HR, Burgart LJ, Harrington JJ, Mahoney DW, Zinsmeister AR, Thibodeau SN, Ahlquist DA.

Clin Gastroenterol Hepatol. 2008 Dec;6(12):1385-8. doi: 10.1016/j.cgh.2008.04.027. Epub 2008 Jul 17.

PMID:
18639494
11.

Highly methylated genes in colorectal neoplasia: implications for screening.

Zou H, Harrington JJ, Shire AM, Rego RL, Wang L, Campbell ME, Oberg AL, Ahlquist DA.

Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2686-96.

12.

Sleep and older patients.

Harrington JJ, Lee-Chiong T Jr.

Clin Chest Med. 2007 Dec;28(4):673-84, v. Review.

PMID:
17967287
13.

Sleep problems in primary care: a North Carolina Family Practice Research Network (NC-FP-RN) study.

Alattar M, Harrington JJ, Mitchell CM, Sloane P.

J Am Board Fam Med. 2007 Jul-Aug;20(4):365-74.

14.

Detection of colorectal disease by stool defensin assay: an exploratory study.

Zou H, Harrington JJ, Sugumar A, Klatt KK, Smyrk TC, Ahlquist DA.

Clin Gastroenterol Hepatol. 2007 Jul;5(7):865-8. Epub 2007 May 24.

PMID:
17531545
15.

Sleep medicine content of major medical textbooks continues to be underrepresented.

Teodorescu MC, Avidan AY, Teodorescu M, Harrington JJ, Artar AO, Davies CR, Chervin RD.

Sleep Med. 2007 Apr;8(3):271-6. Epub 2007 Mar 21.

PMID:
17369089
16.

A sensitive method to quantify human long DNA in stool: relevance to colorectal cancer screening.

Zou H, Harrington JJ, Klatt KK, Ahlquist DA.

Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1115-9.

17.

Aberrant methylation of the eyes absent 4 gene in ulcerative colitis-associated dysplasia.

Osborn NK, Zou H, Molina JR, Lesche R, Lewin J, Lofton-Day C, Klatt KK, Harrington JJ, Burgart LJ, Ahlquist DA.

Clin Gastroenterol Hepatol. 2006 Feb;4(2):212-8.

PMID:
16469682
18.

Identification of novel and improved antimitotic agents derived from noscapine.

Anderson JT, Ting AE, Boozer S, Brunden KR, Crumrine C, Danzig J, Dent T, Faga L, Harrington JJ, Hodnick WF, Murphy SM, Pawlowski G, Perry R, Raber A, Rundlett SE, Stricker-Krongrad A, Wang J, Bennani YL.

J Med Chem. 2005 Nov 17;48(23):7096-8.

PMID:
16279766
19.

Identification of a novel extracellular cation-sensing G-protein-coupled receptor.

Pi M, Faber P, Ekema G, Jackson PD, Ting A, Wang N, Fontilla-Poole M, Mays RW, Brunden KR, Harrington JJ, Quarles LD.

J Biol Chem. 2005 Dec 2;280(48):40201-9. Epub 2005 Sep 30.

20.

Treatment of sleep disorders in elderly patients.

Harrington JJ, Avidan AY.

Curr Treat Options Neurol. 2005 Sep;7(5):339-52.

PMID:
16079039
21.

The application of RAGE and GECKO in cell-based target discovery screens.

Brunden K, Sherf B, Harrington J.

Pharmacogenomics. 2005 Jun;6(4):383-92. Review.

PMID:
16004556
22.

Generation of cell lines for drug discovery through random activation of gene expression: application to the human histamine H3 receptor.

Song J, Doucette C, Hanniford D, Hunady K, Wang N, Sherf B, Harrington JJ, Brunden KR, Stricker-Krongrad A.

Assay Drug Dev Technol. 2005 Jun;3(3):309-18.

PMID:
15971992
23.

Discovery of S-phase arresting agents derived from noscapine.

Anderson JT, Ting AE, Boozer S, Brunden KR, Danzig J, Dent T, Harrington JJ, Murphy SM, Perry R, Raber A, Rundlett SE, Wang J, Wang N, Bennani YL.

J Med Chem. 2005 Apr 21;48(8):2756-8.

PMID:
15828811
24.

Aberrant methylation of secreted frizzled-related protein genes in esophageal adenocarcinoma and Barrett's esophagus.

Zou H, Molina JR, Harrington JJ, Osborn NK, Klatt KK, Romero Y, Burgart LJ, Ahlquist DA.

Int J Cancer. 2005 Sep 10;116(4):584-91.

25.

Frequent methylation of eyes absent 4 gene in Barrett's esophagus and esophageal adenocarcinoma.

Zou H, Osborn NK, Harrington JJ, Klatt KK, Molina JR, Burgart LJ, Ahlquist DA.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):830-4.

26.

Isosteric ramatroban analogs: selective and potent CRTH-2 antagonists.

Robarge MJ, Bom DC, Tumey LN, Varga N, Gleason E, Silver D, Song J, Murphy SM, Ekema G, Doucette C, Hanniford D, Palmer M, Pawlowski G, Danzig J, Loftus M, Hunady K, Sherf BA, Mays RW, Stricker-Krongrad A, Brunden KR, Harrington JJ, Bennani YL.

Bioorg Med Chem Lett. 2005 Mar 15;15(6):1749-53.

PMID:
15745833
27.

High-throughput target discovery using cell-based genetics.

Jackson PD, Harrington JJ.

Drug Discov Today. 2005 Jan 1;10(1):53-60. Review.

PMID:
15676299
28.

Prospective evaluation of fecal calprotectin as a screening biomarker for colorectal neoplasia.

Limburg PJ, Devens ME, Harrington JJ, Diehl NN, Mahoney DW, Ahlquist DA.

Am J Gastroenterol. 2003 Oct;98(10):2299-305.

PMID:
14572583
29.

3-Chloro-4-(dichloromethyl)-5-hydroxy-2(5H)-furanone (MX) and mutagenic activity in Massachusetts drinking water.

Wright JM, Schwartz J, Vartiainen T, Mäki-Paakkanen J, Altshul L, Harrington JJ, Dockery DW.

Environ Health Perspect. 2002 Feb;110(2):157-64. Erratum in: Environ Health Perspect 2002 Jul;110(7):A386.

30.

Detection of occult upper gastrointestinal tract bleeding: performance differences in fecal occult blood tests.

Harewood GC, McConnell JP, Harrington JJ, Mahoney DW, Ahlquist DA.

Mayo Clin Proc. 2002 Jan;77(1):23-8.

PMID:
11794453
31.

Creation of genome-wide protein expression libraries using random activation of gene expression.

Harrington JJ, Sherf B, Rundlett S, Jackson PD, Perry R, Cain S, Leventhal C, Thornton M, Ramachandran R, Whittington J, Lerner L, Costanzo D, McElligott K, Boozer S, Mays R, Smith E, Veloso N, Klika A, Hess J, Cothren K, Lo K, Offenbacher J, Danzig J, Ducar M.

Nat Biotechnol. 2001 May;19(5):440-5.

PMID:
11329013
32.

Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel.

Ahlquist DA, Skoletsky JE, Boynton KA, Harrington JJ, Mahoney DW, Pierceall WE, Thibodeau SN, Shuber AP.

Gastroenterology. 2000 Nov;119(5):1219-27.

PMID:
11054379
33.

Fecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhea referred for colonoscopy.

Limburg PJ, Ahlquist DA, Sandborn WJ, Mahoney DW, Devens ME, Harrington JJ, Zinsmeister AR.

Am J Gastroenterol. 2000 Oct;95(10):2831-7.

PMID:
11051356
34.

Immunodiscrimination of colorectal neoplasia using MUC1 antibodies: discrepant findings in tissue versus stool.

Limburg PJ, Ahlquist DA, Gilbert JA, Harrington JJ, Klee GG, Roche PC.

Dig Dis Sci. 2000 Mar;45(3):494-9.

PMID:
10749323
35.

Mycobacterium tuberculosis lipid antigens: use of multi-antigen based enzyme immunoassay for free and complex dissociated antibodies.

Harrington JJ 3rd, Ho JL, Lapa e Silva JR, Conde MB, Kritski AL, Fonseca LS, Saad MH.

Int J Tuberc Lung Dis. 2000 Feb;4(2):161-7.

PMID:
10694095
36.
37.

Formation of de novo centromeres and construction of first-generation human artificial microchromosomes.

Harrington JJ, Van Bokkelen G, Mays RW, Gustashaw K, Willard HF.

Nat Genet. 1997 Apr;15(4):345-55.

PMID:
9090378
38.

DNA structural elements required for FEN-1 binding.

Harrington JJ, Lieber MR.

J Biol Chem. 1995 Mar 3;270(9):4503-8.

39.

Sequence of human FEN-1, a structure-specific endonuclease, and chromosomal localization of the gene (FEN1) in mouse and human.

Hiraoka LR, Harrington JJ, Gerhard DS, Lieber MR, Hsieh CL.

Genomics. 1995 Jan 1;25(1):220-5.

PMID:
7774922
41.

The characterization of a mammalian DNA structure-specific endonuclease.

Harrington JJ, Lieber MR.

EMBO J. 1994 Mar 1;13(5):1235-46.

42.

IEEE P1157 MEDIX: a standard for open systems medical data interchange.

Harrington JJ.

Ann N Y Acad Sci. 1992 Dec 17;670:116-26. No abstract available.

PMID:
1309079
44.

Chemically sensitized erythrocytes for hemagglutination reactions.

Harrington JJ, Gordon RE, Ross JP, Kobilinsky L.

J Forensic Sci. 1990 Sep;35(5):1115-24.

PMID:
1700058
45.

Detection of hemagglutinins in dried saliva stains and their potential use in blood typing.

Harrington JJ, Martin R, Kobilinsky L.

J Forensic Sci. 1988 May;33(3):628-37.

PMID:
3385376
46.

Detection and use of salivary hemagglutinins for forensic blood grouping.

Kobilinsky L, Harrington JJ.

J Forensic Sci. 1988 Mar;33(2):396-403.

PMID:
3373156
47.

Premature opening of the aortic valve: an index of highly advanced aortic regurgitation.

Pietro DA, Parisi AF, Harrington JJ, Askenazi J.

J Clin Ultrasound. 1978 Jun;6(3):170-2. No abstract available.

PMID:
97320
48.

Ventricular pacemaker wire simulating a right atrial mass.

Kendrick MH, Harrington JJ, Sharma GV, Askenazi J, Parisi AF.

Chest. 1977 Nov;72(5):649-50. No abstract available.

PMID:
913147
49.

Pseudoaneurysm of the left ventricle: an unusual echocardiographic presentation. Review of the literature.

Davidson KH, Parisi AF, Harrington JJ, Barsamian EM, Fishbein MC.

Ann Intern Med. 1977 Apr;86(4):430-3. Review.

PMID:
322561
50.

Echocardiography and tumor invasion of the heart.

Kurzel RB, Parisi AF, Harrington JJ, Barsamian EM.

JAMA. 1976 Dec 6;236(23):2601. No abstract available.

PMID:
1036528

Supplemental Content

Loading ...
Support Center